Form 4 for BVS Bioventus Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0001578563-24-000253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-10 | 2024-06-06 | BVS | Bartholdson John A. | Dir, 10% | M - OptEx | $0.00 | +7,576 | 15.2K | +100% | $0 |
| D | 2024-06-10 | 2024-06-06 | BVS | Bartholdson John A. | Dir, 10% | M - OptEx | $0.00 | -7,576 | 7,575 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-06 | M | A | 7,576 | $0.00 | 15,152 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-06-06 | M | D | 7,576 | $0.00 | 7,575 | D | — · — to — | 7,576 Class A Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F4) 7,576 RSUs vested on each of June 6, 2023 and 2024. The remaining 7,575 RSUs shall vest and become exercisable on June 6, 2025, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. |